SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Sunesis Pharmaceuticals Q3 EPS $(0.06) Beats $(0.08) Estimate

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 66.67 percent increase over losses of $(0.18) per share

Benzinga · -

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 66.67 percent increase over losses of $(0.18) per share from the same period last year.